SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways

Lulu Han,Meng‐Wei Zhuang,Jian Deng,Yi Zheng,Jing Zhang,Mei‐Ling Nan,Xue‐Jing Zhang,Chengjiang Gao,Pei‐Hui Wang
DOI: https://doi.org/10.1002/jmv.27050
IF: 20.693
2021-05-09
Journal of Medical Virology
Abstract:<p>The suppression of the type I and III interferon (IFN) responses by SARS‐CoV‐2 contributes to the pathogenesis of COVID‐19. The strategy used by SARS‐CoV‐2 to evade antiviral immunity needs further investigation. Here, we reported that SARS‐CoV‐2 ORF9b inhibited type I and III IFN production by targeting multiple molecules of innate antiviral signaling pathways. SARS‐CoV‐2 ORF9b impaired the induction of type I and III IFNs by Sendai virus and poly (I:C). SARS‐CoV‐2 ORF9b inhibited the activation of type I and III IFNs induced by the components of cytosolic dsRNA‐sensing pathways of RIG‐I/MDA5‐MAVS signaling, including RIG‐I, MDA‐5, MAVS, TBK1, and IKKε, rather than IRF3‐5D, which is the active form of IRF3. SARS‐CoV‐2 ORF9b also suppressed the induction of type I and III IFNs by TRIF and STING, which are the adaptor protein of the endosome RNA‐sensing pathway of TLR3‐TRIF signaling and the adaptor protein of the cytosolic DNA‐sensing pathway of cGAS‐STING signaling, respectively. A mechanistic analysis revealed that the SARS‐CoV‐2 ORF9b protein interacted with RIG‐I, MDA‐5, MAVS, TRIF, STING, and TBK1 and impeded the phosphorylation and nuclear translocation of IRF3. In addition, SARS‐CoV‐2 ORF9b facilitated the replication of the vesicular stomatitis virus. Therefore, the results showed that SARS‐CoV‐2 ORF9b negatively regulates antiviral immunity and thus facilitates viral replication. This study contributes to our understanding of the molecular mechanism through which SARS‐CoV‐2 impairs antiviral immunity and provides an essential clue to the pathogenesis of COVID‐19.</p><p>This article is protected by copyright. All rights reserved.</p>
virology
What problem does this paper attempt to address?
The key problem that this paper attempts to solve is to explore how the ORF9b protein of SARS - CoV - 2 inhibits the production of type I and type III interferons (IFN), thereby revealing the specific mechanism by which the novel coronavirus evades the host antiviral immunity. Specifically, the research aims to: 1. **Clarify the function of the SARS - CoV - 2 ORF9b protein**: Investigate whether and how the SARS - CoV - 2 ORF9b protein inhibits the production of type I and type III interferons activated by the RIG - I/MDA5 - MAVS, TLR3 - TRIF and cGAS - STING signaling pathways. 2. **Reveal its mechanism of action**: Determine the specific action sites of SARS - CoV - 2 ORF9b in the antiviral innate immune signaling pathways, especially how it interacts with the key molecules in these pathways, and then inhibits the phosphorylation and nuclear transport of IRF3. 3. **Evaluate its impact on virus infection**: Verify whether SARS - CoV - 2 ORF9b promotes virus replication by inhibiting the antiviral immune response, especially in cell models. ### Specific questions - **How does SARS - CoV - 2 ORF9b affect the production of type I and type III interferons?** - The study found that SARS - CoV - 2 ORF9b can significantly inhibit the expression of IFN - β, IFN - λ1 and their downstream ISGs (such as ISG56 and CXCL10) induced by SeV infection or poly(I:C) transfection. - **In which signaling pathways does SARS - CoV - 2 ORF9b play a role?** - SARS - CoV - 2 ORF9b mainly inhibits the upstream signal transduction by targeting multiple molecules in the RIG - I/MDA5 - MAVS, TLR3 - TRIF and cGAS - STING signaling pathways, but does not affect the active form of IRF3 (IRF3 - 5D). - **How does SARS - CoV - 2 ORF9b inhibit the phosphorylation of TBK1?** - Research shows that SARS - CoV - 2 ORF9b can prevent the phosphorylation of TBK1 induced by signal molecules such as RIG - IN, MAVS and STING, thereby blocking the phosphorylation and nuclear transport of IRF3. - **What is the impact of SARS - CoV - 2 ORF9b on virus infection?** - The experimental results show that SARS - CoV - 2 ORF9b not only inhibits the production of IFN, but also promotes the replication of VSV (vesicular stomatitis virus), further confirming its role in promoting virus replication. Through these studies, the authors revealed that SARS - CoV - 2 ORF9b, as a new immune escape factor, can inhibit the host antiviral immune response in multiple ways, providing important clues for understanding the pathogenic mechanism of the novel coronavirus and a theoretical basis for the development of treatment strategies against the novel coronavirus.